Genotype distribution of hepatitis C in Cordoba City, Argentina;Distribución de genotipos de hepatitis C en la ciudad de Córdoba, Argentina

Revista de Gastroenterologia de Mexico

Volumn 75, Issue 3, 2010, Pages 287-292

  Ruiz, R D ^a   Bisaro L B ^a   German, J C ^b   Grutadauria, S ^c  

^a Laboratorio Privado Unidad de Hígado Córdoba   (Argentina)

^b Centro Médico Privado Hepato   (Argentina)

^c Sanatorio Allende   (Argentina)

Author keywords

Argentina; Genotype; Hepatitis C; Risk factors; Viral hepatitis; Viral load

Indexed keywords

ADULT; AGED; ARGENTINA; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; VIROLOGY; VIRUS LOAD;

ADULT; AGED; ARGENTINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 84865786403     PISSN: 03750906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Choo QL, Kuo G, Weiner AJ, et al. Isolation of cDNA derived from bloodborne non-A, non-B hepatitis genome. Science 1989;244:359-362.
2. Simmonds P, Bukh J, Combet C, et al. Consensus p proposals for a unififi ed system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962-973.
3. Navarro-Ortega D, Jimenez-Mayordomo M, Martinez-Aparicio MD. Métodos moleculares para la determinación del genotipo del virus de la hepatitis C. Enferm Infecc Microbiol Clin 2007;25:66-71.
4. Simmonds P. Genetic diversity and evolution of hepatitis C virus -15 years on. J Gen Virol 2004 85:3173-3188.
5. Kuiken C, Yusim K, Boykin L, et al. The Los Alamos hepatitis C sequence database. Bioinformatics 2005;21:379-384.
6. Lamballerie X, Charrel RN, Attoui H, et al. Classification of hepatitis C virus variants in six major types based on analyses of the envelope 1 and nonstructural 5B genome regions and complete polyprotein sequences. J Gen Virol 1997;78:45-51.
7. Zein N. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Reviews 2000; 13:223-235.
8. Pujol F, Loureiro C. Remplacement of hepatitis C virus genotype 1b by genotype 2 over a 10 year period in Venezuela. J Clin Gastrenterol 2007; 41:518-520.
9. Fassio E, Schroder T, Asociación Argentina para el Estudio de las Enfermedades del Hígado. Conclusiones del Consenso Argentino Hepatitis C 2007. Acta Gastroenterol.Latinoam 2008;38:56-74.
10. Ré V, Lampe E, Yoshida CF, et al. Hepatitis C virus genotypes in Córdoba, Argentina. Unexpected high prevalence of genotype 2. Medicina (B. Aires) 2003;63:205-210.
11. Benitez Arvizu G, Cortez Gomez R, Novelo Garza BA, y cols. Prevalencia del virus de hepatitis C en el banco de sangre del Centro Médico Nacional La Raza. Rev Med Inst Mex Seguro Soc 2006; 44:227-233.
12. Chirinos de Rivero LF, Campos Nizama J, Castro Valdivia R, y cols. Perfil epidemiológico de los pacientes con hepatitis crónica por virus C y se respuesta virológica temprana al tratamiento con Interferón Pegilado mas Ribavirina. Rev Gastroenterol Perú 2007;27:27-36.
13. Quarleri JF, Robertson BH, Mathet VL, et al.Genomic and phylogenetic analysis of hepatitis C virus isolates from Argentine patients: a six-year retrospective study. J Clin Microbiol 2000;38:4560-4568.
14. Márquez-Rosales M, Santoscoy-Tovar F, Montoya-Fuentes H. Frecuencia y distribución de genotipos del virus de la hepatitis C en la población mexicana seleccionada. Rev Mex Patol Clin 2008;55:79-87.
15. Rustigi V. The epidemiology of hepatitis C infection in the United States. J Gastroenterol 2007;42:513-521.
16. Muñoz Espinosa LE, Rizo Robles M, Moreno Terrones L, y cols. Guías clínicas de diagnóstico y tratamiento de Hepatitis C. Rev Gastroenterol Mex 2007;72:185-188.
17. Zeuzem S, Diago M, Gane E, et al. Peginterferon alfa-2° (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. Gastroenterology 2004;127:1724-1732.
18. Pereira H, Cavalheiro N, Tengan F, et al Patients with chronic hepatitis C and normal transaminases. Rev Inst Med Trop S Paul 2005;47:247-251.
19. Colina R, Mogdasy MC, Cristina J, y cols. Caracterización molecular del virus de la hepatitis C en Montevideo-Uruguay. Rev Med Uruguay 2002;18:76-82
20. Nainan O, Alter M, Moran-Kruszon D, et al. Hepatitis C virus genotypes and viral concentrations in participants of a general population Surrey in the United States. Gastroenterology 2006; 131:478-484.
21. National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C. Hepatology 2002;36(5 Suppl. 1):S3-S20.
22. Idrovo V Aproximación terapéutica a la hepatitis por virus C. Rev Col Gastroenterol 2006; 21:33-37.
23. Hoofnagle J and Seef L. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 2006;355:2444-51.
24. Pawlotsky JM. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 2003;59:1-11.
25. Muir AJ, Bornstein JD, Killerberg PG, et al. Peginterferon alfa-2b and ribavirn for the treatment of chronic hepatitis C in blacks and non-hispanic whites. N Engl J Med 2004;350:2265-71.